Aminah Jatoi
About
Aminah Jatoi is a scholar working on Oncology, Physiology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Aminah Jatoi has authored 400 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Oncology, 91 papers in Physiology and 88 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aminah Jatoi's work include Nutrition and Health in Aging (61 papers), Cancer survivorship and care (40 papers) and Lung Cancer Treatments and Mutations (40 papers). Aminah Jatoi is often cited by papers focused on Nutrition and Health in Aging (61 papers), Cancer survivorship and care (40 papers) and Lung Cancer Treatments and Mutations (40 papers). Aminah Jatoi collaborates with scholars based in United States, Germany and Canada. Aminah Jatoi's co-authors include Charles L. Loprinzi, Vickie E. Baracos, Neil Macdonald, Maurizio Muscaritoli, Mellar P. Davis, Éduardo Bruera, Ingvar Bosæus, Declan Walsh, Stein Kaasa and Kenneth Fearon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
In The Last Decade
Aminah Jatoi
382 papers receiving 13.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aminah Jatoi United States | 50 | 5.8k | 4.6k | 2.6k | 2.4k | 1.9k | 400 | 13.6k | ||
| Bette J. Caan United States | 88 | 6.5k 1.1× | 10.1k 2.2× | 2.3k 0.9× | 4.3k 1.8× | 2.1k 1.1× | 425 | 24.1k | ||
| Charles L. Loprinzi United States | 91 | 8.2k 1.4× | 15.5k 3.3× | 5.2k 2.0× | 3.6k 1.5× | 3.4k 1.8× | 531 | 33.3k | ||
| Andrew Wilcock United Kingdom | 35 | 4.0k 0.7× | 1.6k 0.3× | 1.1k 0.4× | 1.1k 0.5× | 906 0.5× | 138 | 7.3k | ||
| Jeffrey A. Meyerhardt United States | 85 | 5.0k 0.9× | 16.3k 3.5× | 4.3k 1.6× | 5.3k 2.2× | 3.3k 1.8× | 431 | 25.8k | ||
| Marilyn L. Kwan United States | 53 | 1.8k 0.3× | 4.6k 1.0× | 1.0k 0.4× | 1.4k 0.6× | 870 0.5× | 197 | 8.9k | ||
| Bernd Holleczek Germany | 48 | 1.2k 0.2× | 2.6k 0.6× | 1.2k 0.5× | 1.7k 0.7× | 942 0.5× | 237 | 8.0k | ||
| Catherine M. Alfano United States | 65 | 3.2k 0.6× | 9.0k 1.9× | 2.7k 1.0× | 1.9k 0.8× | 1.0k 0.5× | 188 | 16.6k | ||
| Rowan T. Chlebowski United States | 79 | 3.2k 0.6× | 13.3k 2.9× | 2.7k 1.0× | 4.3k 1.8× | 1.3k 0.7× | 454 | 24.9k | ||
| Cornelia M. Ulrich United States | 72 | 3.6k 0.6× | 6.2k 1.3× | 1.7k 0.6× | 5.2k 2.2× | 1.6k 0.8× | 354 | 18.2k | ||
| Susan S. Jick United States | 64 | 2.0k 0.3× | 1.7k 0.4× | 1.5k 0.6× | 2.9k 1.2× | 2.7k 1.4× | 321 | 16.9k |
Countries citing papers authored by Aminah Jatoi
Since
Specialization
Citations
This map shows the geographic impact of Aminah Jatoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aminah Jatoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aminah Jatoi more than expected).
Fields of papers citing papers by Aminah Jatoi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Aminah Jatoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aminah Jatoi. The network helps show where Aminah Jatoi may publish in the future.
Co-authorship network of co-authors of Aminah Jatoi
This figure shows the co-authorship network connecting the top 25 collaborators of Aminah Jatoi. A scholar is included among the top collaborators of Aminah Jatoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aminah Jatoi. Aminah Jatoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Morrison, Vicki A., et al.. (2025). Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303. Journal of Geriatric Oncology. 16(2). 102185–102185.
2.
Fee-Schroeder, Kelliann C., et al.. (2025). Homelessness and Cancer: A Multi-Site, Mixed Methods Study of Delayed or No Cancer Therapy. American Journal of Hospice and Palliative Medicine®. 43(2). 179–187.
3.
Hendrickson, Andrea E. Wahner, Nathan R. Foster, Matthew S. Block, et al.. (2024). Phase II clinical trial of PLX038 in patients with platinum resistant ovarian, primary peritoneal and fallopian tube cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS5630–TPS5630.
4.
Weaver, Amy L., Michael R. Moynagh, Naoki Takahashi, et al.. (2022). Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. International Journal of Gynecological Cancer. 32(10). 1289–1296.
5.
Jatoi, Aminah, et al.. (2021). Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?. Current Treatment Options in Oncology. 22(4). 31–31.
6.
Le‐Rademacher, Jennifer, et al.. (2021). Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting. Breast Cancer Research and Treatment. 188(1). 15–20.
7.
Le‐Rademacher, Jennifer, et al.. (2021). Dexamethasone and hiccups: a 2000-patient, telephone-based study. BMJ Supportive & Palliative Care. 13(e3). e790–e793.
8.
Gile, Jennifer, Fang‐Shu Ou, Amit Mahipal, et al.. (2021). FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO Precision Oncology. 5(5). 1228–1240.
9.
Childs, Daniel S., et al.. (2020). Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Supportive Care in Cancer. 29(2). 733–739.
10.
Pondé, Noam, Dominique Agbor‐Tarh, Lissandra Dal Lago, et al.. (2020). Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D). Breast Cancer Research and Treatment. 185(1). 107–116.
11.
Sedrak, Mina S., Rachel A. Freedman, Harvey Jay Cohen, et al.. (2020). Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA A Cancer Journal for Clinicians. 71(1). 78–92.
12.
Cathcart-Rake, Elizabeth, Jennifer L. Ridgeway, Carmen Radecki Breitkopf, et al.. (2019). Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers. American Journal of Hospice and Palliative Medicine®. 37(6). 418–423.
13.
Li, Daneng, Linda McCall, Olwen Hahn, et al.. (2018). Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study. Breast Cancer Research and Treatment. 171(2). 325–334.
14.
Hendrickson, Andrea Wahner, et al.. (2018). Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?. American Journal of Hospice and Palliative Medicine®. 36(1). 72–75.
15.
Antwi, Samuel O., William R. Bamlet, Kari G. Chaffee, et al.. (2017). Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 26(6). 971–974.
16.
Hopkins, Judith O., Jake Allred, Arti Hurria, et al.. (2017). Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302). Breast Cancer Research and Treatment. 166(3). 793–808.
17.
Jatoi, Aminah, Carmen Radecki Breitkopf, Nathan R. Foster, et al.. (2014). A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients. Oncology. 88(4). 208–213.
18.
Jatoi, Aminah & Carmen Radecki Breitkopf. (2011). Is Spanish Language a Barrier to Domestic Violence Assessment?. Journal of Women s Health. 20(7). 1111–1116.
19.
Mateen, Farrah J. & Aminah Jatoi. (2006). Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clinical Nutrition. 25(5). 711–715.
20.
Jatoi, Aminah, Shauna L. Hillman, Philip J. Stella, et al.. (2005). Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group. Journal of Clinical Oncology. 23(36). 9113–9119.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bette J. Caan Breakdown of academic impact, for papers by Charles L. Loprinzi Breakdown of academic impact, for papers by Andrew Wilcock Breakdown of academic impact, for papers by Jeffrey A. Meyerhardt Breakdown of academic impact, for papers by Marilyn L. Kwan Breakdown of academic impact, for papers by Bernd Holleczek Breakdown of academic impact, for papers by Catherine M. Alfano Breakdown of academic impact, for papers by Rowan T. Chlebowski Breakdown of academic impact, for papers by Cornelia M. Ulrich Breakdown of academic impact, for papers by Susan S. Jick